StockMarketWire.com - Shore Capital today reaffirms its buy investment rating on Verona Pharma PLC [LON:VRP] and cut its price target to 160p (from 173p).

Story provided by StockMarketWire.com

Broker Forecasts data provided by www.sharesmagazine.co.uk